Expression of PerRA and PerRB in <i>L</i>. <i>interrogans</i> wild-type and mutant strains. by André A. Grassmann (11141592)

Image_5_Blood immune cell profiling in adults with longstanding type 1 diabetes is associated with macrovascular complications.jpeg by Xuehui He (2805751)

Image_5_Association Between Water Intake and Mortality Risk—Evidence From a National Prospective Study.jpg by Hao-long Zhou (11634697)

Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…DLBCL cohort analysis found that RAB39B expression was related to 14 m6A modifier genes, including YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, RBMX, ZC3H13, METTL14, METTL3, RBM15, RBM15B, VIRMA, FTO, and ALKBH5. We constructed 14 possible ceRNA networks of RAB39B in DLBCL. …”

Pseudo first-order rate constants for CIII formation (<i>k</i> CIII(obs)), enzyme inactivation (<i>k</i>_i(obs)) and heme bleaching (<i>k</i>_b(obs)) of native... by Verónica Sáez-Jiménez (731925)

“…CIII formation was measured as the absorbance increase at 581 nm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124750#pone.0124750.g008" target="_blank">Fig 8A</a>) and heme bleaching as the absorbance decrease at 419 nm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124750#pone.0124750.g008" target="_blank">Fig 8B</a>). …”

Vitamin A deficiency indicating as low expression of LRAT may be a novel biomarker of primary hypertension by Xiaohua Liang (535684)

“…<p>Vitamin A (VA) deficiency triggers many diseases and is a worldwide nutrition problem. …”

Data_Sheet_5_v1_The mTOR inhibitor rapamycin suppresses trigeminal neuropathic pain and p-MKK4/p-p38 mitogen-activated protein kinase-mediated microglial activation in the trigemin... by Ji-Hee Yeo (15288553)

Table 5_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

“…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”

Table_5_Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.xlsx by Aleksandra Stanisavljevic (9245209)

Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

Individual biometric data of patients. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

Early reduction in total cholesterol to high-density lipoprotein cholesterol ratio predicts hydroxychloroquine efficacy in treating IgA nephropathy by Yaotong Shi (19511899)

“…</p> <p>Patients in the high TC/HDL-C decline rate group with ≥50% decrease in proteinuria from baseline experienced a significant improvement during the follow-up. …”

Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”